Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP719975.RAGolioy0xgQ53TppBuVUCe0vQVuc1-FEfbbfNtIfD-KA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP719975.RAGolioy0xgQ53TppBuVUCe0vQVuc1-FEfbbfNtIfD-KA130_assertion type Assertion NP719975.RAGolioy0xgQ53TppBuVUCe0vQVuc1-FEfbbfNtIfD-KA130_head.
- NP719975.RAGolioy0xgQ53TppBuVUCe0vQVuc1-FEfbbfNtIfD-KA130_assertion description "[The Fip1-like-1-platelet-derived growth factor receptor alpha (FIP1L1-PDGFRA) gene fusion is a common cause of chronic eosinophilic leukemia (CEL)/hypereosinophilic syndrome (HES), and patients suffering from this particular subgroup of CEL/HES respond to low-dose imatinib therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP719975.RAGolioy0xgQ53TppBuVUCe0vQVuc1-FEfbbfNtIfD-KA130_provenance.
- NP719975.RAGolioy0xgQ53TppBuVUCe0vQVuc1-FEfbbfNtIfD-KA130_assertion evidence source_evidence_literature NP719975.RAGolioy0xgQ53TppBuVUCe0vQVuc1-FEfbbfNtIfD-KA130_provenance.
- NP719975.RAGolioy0xgQ53TppBuVUCe0vQVuc1-FEfbbfNtIfD-KA130_assertion SIO_000772 19210352 NP719975.RAGolioy0xgQ53TppBuVUCe0vQVuc1-FEfbbfNtIfD-KA130_provenance.
- NP719975.RAGolioy0xgQ53TppBuVUCe0vQVuc1-FEfbbfNtIfD-KA130_assertion wasDerivedFrom befree-2016 NP719975.RAGolioy0xgQ53TppBuVUCe0vQVuc1-FEfbbfNtIfD-KA130_provenance.
- NP719975.RAGolioy0xgQ53TppBuVUCe0vQVuc1-FEfbbfNtIfD-KA130_assertion wasGeneratedBy ECO_0000203 NP719975.RAGolioy0xgQ53TppBuVUCe0vQVuc1-FEfbbfNtIfD-KA130_provenance.